Immunomodulatory action of levamisole — I. Structural analysis and immunomodulating activity of levamisole degradation products

This publication has 26 references indexed in Scilit:

• Immunomodulatory action of levamisole — II. Enhancement of concanavalin a response by levamisole is associated with an oxidation degradation product of levamisole formed during lymphocyte culture
  International Journal of Immunopharmacology, 1991
• Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double-blind randomized clinical trial
  British Journal of Surgery, 1989
• Effect of levamisole and azathioprine on the human mixed lymphocyte reaction (MLR).
  British Journal of Clinical Pharmacology, 1984
• The dosage regimen of levamisole in cancer: Is it related to efficacy and safety?
  International Journal of Immunopharmacology, 1983
• Prevention of peroxidase mediated inhibition of neutrophil motility and lymphocyte transformation by levamisole, OMPI, sodium aurothiomalate, indomethacin and tolmetin in vitro
  International Journal of Immunopharmacology, 1981
• Protective effect of levamisole and its sulfhydryl metabolite OMPI against cell death induced by glutathione depletion
  International Journal of Immunopharmacology, 1979
• Lymphocyte surface poisons: Disulfides and thiolsulfonates
  Chemico-Biological Interactions, 1978
• Levamisole: its stability in aqueous solutions at elevated temperatures. Part I. Isolation and identification of decomposition products formed in aqueous solutions of levamisole stored under nitrogen and oxygen at 100 °C
  The Analyst, 1971
• Levamisole: its stability in aqueous solutions at elevated temperatures. Part III. A chromatographic and polarimetric study of the kinetics of degradation
  The Analyst, 1971
• AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINS
  Transplantation, 1968